Concepedia
Publication | Open Access
Ibrutinib Plus Venetoclax for First-line Treatment of Chronic Lymphocytic Leukemia
108
Citations
18
References
2021
Year
ClinicalTrials.gov Identifier: NCT02756897.
Page 1